Consultants in Cardiovascular Medicine is categorized under Medical Centers in Melrose Park, IL and active since 2000.
Consultants in Cardiovascular Medicine was established in 2000, and today employs 1 to 4, earning Unknown per year. This is a Medical Centers business, which does work in the B2C market, and is classified as a Medical Centers, under code number by the NAICS.
If you are seeking more information, feel free to contact Ajanta De at the company’s single location by writing to 675 W. North Ave.,
Suite 210, Melrose Park, Illinois IL 60160 or by phoning (708) 838-1448. You can also visit this business on Facebook by going to their profile page at Facebook or on find them on Twitter.
| Business Name: | Consultants in Cardiovascular Medicine |
| Contact Person: | Ajanta De |
| Address: | 675 W. North Ave., Suite 210, Melrose Park, Illinois 60160 |
| Phone Number: | (708) 838-1448 |
| Website Address: | ccmconsultants.com |
| Annual Revenue (USD): | Unknown |
| Founded: | 2000 |
| Location Type: | Single Location |
| Employee Number: | 1 to 4 |
| Business Type: | B2C (Business to Consumer) |
| Business Category: | Medical Centers |
| Share This Business: |
Consultants in Cardiovascular Medicine was started in 2000 to provide professional Medical Centers under the SIC code and NAICS code . Since its inception, the company has gone on to take a total of 1 to 4 personnel under its employment and has achieved earnings of Unknown per annum.
Feel free to contact Ajanta De for inquiries that concern Consultants in Cardiovascular Medicine by calling the company number (708) 838-1448, as your correspondence is most welcome.
Additionally, the physical location of the single location of Consultants in Cardiovascular Medicine can be found at the coordinates 41.908309534192,-87.842 as well as the street address 675 W. North Ave.,
Suite 210 in Melrose Park, Illinois 60160.
For its online presence, you may visit Consultants in Cardiovascular Medicine’s website at ccmconsultants.com and engage with its social media outlets through on Twitter and on Facebook.